{"id":"NCT02066181","sponsor":"National Cancer Institute (NCI)","briefTitle":"Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis","officialTitle":"A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of Sorafenib in Desmoid Tumors or Aggressive Fibromatosis (DT/DF)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03-21","primaryCompletion":"2019-07-03","completion":"2022-12-01","firstPosted":"2014-02-19","resultsPosted":"2019-09-20","lastUpdate":"2023-06-07"},"enrollment":87,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Desmoid Fibromatosis"],"interventions":[{"type":"OTHER","name":"Laboratory Biomarker Analysis","otherNames":[]},{"type":"OTHER","name":"Placebo Administration","otherNames":[]},{"type":"OTHER","name":"Quality-of-Life Assessment","otherNames":["Quality of Life Assessment"]},{"type":"DRUG","name":"Sorafenib Tosylate","otherNames":["BAY 43-9006 Tosylate","BAY 54-9085","Nexavar","sorafenib"]}],"arms":[{"label":"Arm I (sorafenib tosylate)","type":"EXPERIMENTAL"},{"label":"Arm II (placebo)","type":"PLACEBO_COMPARATOR"}],"summary":"This randomized phase III trial compares the effects, good and/or bad, of sorafenib tosylate in treating patients with desmoid tumors or aggressive fibromatosis. Sorafenib tosylate may stop the growth of tumor cells by blocking some of the proteins needed for cell growth. \\[Funding Source - FDA OOPD\\]","primaryOutcome":{"measure":"Progression-free Survival(PFS) Rate","timeFrame":"Time from randomization to the first occurrence of progression or death due to any cause, assessed up to 3 years","effectByArm":[{"arm":"Arm I (Sorafenib Tosylate)","deltaMin":7,"sd":null},{"arm":"Arm II (Placebo)","deltaMin":22,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":19,"exclusionCount":null},"locations":{"siteCount":150,"countries":["United States","Canada"]},"refs":{"pmids":["34420143","33258687","30575484"],"seeAlso":["https://nctn-data-archive.nci.nih.gov/"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":49},"commonTop":["Fatigue","Palmar-plantar erythrodysesthesia syndrome","Hypertension","Nausea","Diarrhea"]}}